Balter Invenomic Annual Yield vs. Net Asset
| BIVRX Fund | USD 17.16 0.25 1.48% |
For Balter Invenomic profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Balter Invenomic to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Balter Invenomic Fund utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Balter Invenomic's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Balter Invenomic Fund over time as well as its relative position and ranking within its peers.
Balter |
Balter Invenomic Net Asset vs. Annual Yield Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Balter Invenomic's current stock value. Our valuation model uses many indicators to compare Balter Invenomic value to that of its competitors to determine the firm's financial worth. Balter Invenomic Fund is rated below average in annual yield among similar funds. It is rated below average in net asset among similar funds making up about 56,575,303,644 of Net Asset per Annual Yield. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Balter Invenomic's earnings, one of the primary drivers of an investment's value.Balter Net Asset vs. Annual Yield
Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Balter Invenomic |
| = | 0.02 % |
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Balter Invenomic |
| = | 1.4 B |
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Balter Net Asset Comparison
Balter Invenomic is rated below average in net asset among similar funds.
Balter Invenomic Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Balter Invenomic, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Balter Invenomic will eventually generate negative long term returns. The profitability progress is the general direction of Balter Invenomic's change in net profit over the period of time. It can combine multiple indicators of Balter Invenomic, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
The fund invests primarily in both long and short positions in equity securities principally traded in United States markets. Under normal market conditions, the Sub-Adviser seeks to be fully invested in the long portfolio , while allowing the size of the short portfolio to fluctuate based on the market opportunity. The fund may invest in equity securities of any type and across all market capitalizations. It may invest in securities of companies operating less than three years and in initial public offerings of securities .
Balter Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Balter Invenomic. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Balter Invenomic position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Balter Invenomic's important profitability drivers and their relationship over time.
| Annual Yield vs Year To Date Return | ||
| One Year Return vs Net Asset | ||
| Annual Yield vs Three Year Return | ||
| Five Year Return vs Net Asset | ||
| Annual Yield vs Cash Position Weight | ||
| Equity Positions Weight vs Net Asset |
Use Balter Invenomic in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Balter Invenomic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Balter Invenomic will appreciate offsetting losses from the drop in the long position's value.Balter Invenomic Pair Trading
Balter Invenomic Fund Pair Trading Analysis
The ability to find closely correlated positions to Balter Invenomic could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Balter Invenomic when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Balter Invenomic - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Balter Invenomic Fund to buy it.
The correlation of Balter Invenomic is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Balter Invenomic moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Balter Invenomic moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Balter Invenomic can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Balter Invenomic position
In addition to having Balter Invenomic in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Aggressive Funds Thematic Idea Now
Aggressive Funds
Funds or Etfs that attempt to achieve high capital gains by investing in companies with high growth potential and above average risk. The Aggressive Funds theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Balter Mutual Fund
To fully project Balter Invenomic's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Balter Invenomic at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Balter Invenomic's income statement, its balance sheet, and the statement of cash flows.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |